Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients

Albert Muñoz-Vendrell, Sergio Campoy, Edoardo Caronna, Alicia Alpuente, Marta Torres-Ferrus, Candela Nieves Castellanos, Marina Olivier, Jaume Campdelacreu, Joan Prat, Javier Camiña Muñiz, Francisco José Molina Martínez, Ane Mínguez-Olaondo, Marta Ruibal Salgado, Sonia Santos Lasaosa, María Pilar Navarro Pérez, Noemí Morollón, Alba López Bravo, Luis Miguel Cano Sánchez, Sonia María García-Sánchez, Jésica García-Ull, Laura Rubio-Flores, Alicia Gonzalez-Martinez, Sonia Quintas, Ana Echavarría Íñiguez, Sendoa Gil Luque, María Victoria Castro-Sánchez, Vanesa Adell Ortega, Jessica García Alhama, Nuria Berrocal-Izquierdo, Robert Belvís, Samuel Díaz-Insa, Patricia Pozo-Rosich, Mariano Huerta-Villanueva

Open source

DOI: 10.1186/s10194-023-01585-2
Published: 2023-06-02
Container: The Journal of Headache and Pain
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s10194-023-01585-2,
  title = {Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients},
  author = {Albert Muñoz-Vendrell and Sergio Campoy and Edoardo Caronna and Alicia Alpuente and Marta Torres-Ferrus and Candela Nieves Castellanos and Marina Olivier and Jaume Campdelacreu and Joan Prat and Javier Camiña Muñiz and Francisco José Molina Martínez and Ane Mínguez-Olaondo and Marta Ruibal Salgado and Sonia Santos Lasaosa and María Pilar Navarro Pérez and Noemí Morollón and Alba López Bravo and Luis Miguel Cano Sánchez and Sonia María García-Sánchez and Jésica García-Ull and Laura Rubio-Flores and Alicia Gonzalez-Martinez and Sonia Quintas and Ana Echavarría Íñiguez and Sendoa Gil Luque and María Victoria Castro-Sánchez and Vanesa Adell Ortega and Jessica García Alhama and Nuria Berrocal-Izquierdo and Robert Belvís and Samuel Díaz-Insa and Patricia Pozo-Rosich and Mariano Huerta-Villanueva},
  year = {2023},
  journal = {The Journal of Headache and Pain},
  doi = {10.1186/s10194-023-01585-2},
  url = {https://doi.org/10.1186/s10194-023-01585-2}
}

RIS

TY  - JOUR
TI  - Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
AU  - Albert Muñoz-Vendrell
AU  - Sergio Campoy
AU  - Edoardo Caronna
AU  - Alicia Alpuente
AU  - Marta Torres-Ferrus
AU  - Candela Nieves Castellanos
AU  - Marina Olivier
AU  - Jaume Campdelacreu
AU  - Joan Prat
AU  - Javier Camiña Muñiz
AU  - Francisco José Molina Martínez
AU  - Ane Mínguez-Olaondo
AU  - Marta Ruibal Salgado
AU  - Sonia Santos Lasaosa
AU  - María Pilar Navarro Pérez
AU  - Noemí Morollón
AU  - Alba López Bravo
AU  - Luis Miguel Cano Sánchez
AU  - Sonia María García-Sánchez
AU  - Jésica García-Ull
AU  - Laura Rubio-Flores
AU  - Alicia Gonzalez-Martinez
AU  - Sonia Quintas
AU  - Ana Echavarría Íñiguez
AU  - Sendoa Gil Luque
AU  - María Victoria Castro-Sánchez
AU  - Vanesa Adell Ortega
AU  - Jessica García Alhama
AU  - Nuria Berrocal-Izquierdo
AU  - Robert Belvís
AU  - Samuel Díaz-Insa
AU  - Patricia Pozo-Rosich
AU  - Mariano Huerta-Villanueva
PY  - 2023
JO  - The Journal of Headache and Pain
DO  - 10.1186/s10194-023-01585-2
UR  - https://doi.org/10.1186/s10194-023-01585-2
ER  -

APA

Muñoz-Vendrell, A., Campoy, S., Caronna, E., Alpuente, A., Torres-Ferrus, M., Castellanos, C. N., Olivier, M., Campdelacreu, J., Prat, J., Muñiz, J. C., Martínez, F. J. M., Mínguez-Olaondo, A., Salgado, M. R., Lasaosa, S. S., Pérez, M. P. N., Morollón, N., Bravo, A. L., Sánchez, L. M. C., García-Sánchez, S. M., García-Ull, J., Rubio-Flores, L., Gonzalez-Martinez, A., Quintas, S., Íñiguez, A. E., Luque, S. G., Castro-Sánchez, M. V., Ortega, V. A., Alhama, J. G., Berrocal-Izquierdo, N., Belvís, R., Díaz-Insa, S., Pozo-Rosich, P., & Huerta-Villanueva, M. (2023). Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients. The Journal of Headache and Pain. https://doi.org/10.1186/s10194-023-01585-2

Source records

crossref · retrieved 2026-09-26T07:56:57.343Z